Suchergebnisse - "Drug Monitoring/methods"
-
1
Autoren: et al.
Quelle: Journal of Thrombosis and Haemostasis. 23:3033-3055
Schlagwörter: Low-Molecular-Weight/adverse effects, drug monitoring, Factor Xa/metabolism, Heparin, factor Xa, heparin, Treatment Outcome, Venous Thromboembolism/blood, Blood Coagulation/drug effects, Factor Xa Inhibitors/blood, Predictive Value of Tests, Risk Factors, Hemorrhage/chemically induced, low-molecular-weight, Humans, Female, Drug Dosage Calculations, venous thrombosis, Anticoagulants/adverse effects, Drug Monitoring/methods, Randomized Controlled Trials as Topic
-
2
Autoren: et al.
Quelle: Scandinavian Journal of Clinical and Laboratory Investigation. 85:108-115
Schlagwörter: Male, Adult, Blood Specimen Collection, feasibility studies, Antirheumatic Agents/therapeutic use, Rheumatic Diseases/drug therapy, Middle Aged, Capillaries, Self Care, Rheumatology, Blood Specimen Collection/methods, Rheumatic Diseases, Antirheumatic Agents, Chemistry techniques, Humans, Feasibility Studies, analytical, capillaries, Female, Drug Monitoring, Drug Monitoring/methods, validation studies, Aged
-
3
Autoren: et al.
Quelle: Seizure, vol. 125, pp. 106-112
Schlagwörter: Male, Adult, Young Adult, Epilepsy, Humans, Reproducibility of Results, Anticonvulsants, Female, Saliva/chemistry, Anticonvulsants/analysis, Anticonvulsants/blood, Drug Monitoring/methods, Drug Monitoring/standards, Middle Aged, Epilepsy/drug therapy, Newer anti-seizure medications, Saliva, Therapeutic drug monitoring, Drug Monitoring
Dateibeschreibung: application/pdf
-
4
Autoren: et al.
Quelle: Chemotherapy
Chemotherapy, vol. 70, no. 2, pp. 92-101Schlagwörter: Male, 0301 basic medicine, Sex Characteristics, Dose-Response Relationship, Drug, Body Surface Area, Antineoplastic Agents, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, Humans, Antineoplastic Agents/pharmacokinetics, Antineoplastic Agents/administration & dosage, Antineoplastic Agents/therapeutic use, Female, Neoplasms/drug therapy, Drug Monitoring/methods, Chemotherapy, Pharmacokinetics, Sex difference, Therapeutic drug monitoring, Neoplasms, Drug Monitoring, Anticancer Section / Review
Dateibeschreibung: application/pdf
-
5
Autoren: et al.
Quelle: Br J Clin Pharmacol
Schlagwörter: Male, Adult, ATP Binding Cassette Transporter, Subfamily B, Genotype, ATP Binding Cassette Transporter, Immunosuppressive Agents/pharmacokinetics, Models, Biological, Tacrolimus, Pregnane X Receptor/genetics, Models, Leukocytes, Mononuclear/metabolism, Humans, Cytochrome P-450 CYP3A, Prospective Studies, Aged, Pregnane X Receptor, Immunology in the medical area, Middle Aged, Subfamily B/genetics, Biological, Kidney Transplantation, Cytochrome P-450 CYP3A/genetics, Immunologi inom det medicinska området, Leukocytes, Mononuclear, Original Article, Female, Tacrolimus/pharmacokinetics, Drug Monitoring, Drug Monitoring/methods, Immunosuppressive Agents
Dateibeschreibung: application/pdf
-
6
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Intensive Care Med
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
INTENSIVE CARE MEDICINESchlagwörter: Male, Bacteremia / drug therapy, IMPACT, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Original, [SDV]Life Sciences [q-bio], Critical Illness / mortality, Bacteremia, Medicine and Health Sciences, EPIDEMIOLOGY, Medicaments antibacterians - Ús terapèutic, Outcome indicator, Prospective Studies, DISEASES::Bacterial Infections and Mycoses::Infection::Cross Infection, Cross Infection, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Intensive Care Units / statistics & numerical data, Middle Aged, Centre, Anti-Bacterial Agents, 3. Good health, [SDV] Life Sciences [q-bio], Europe, Intensive Care Units, Outcome and Process Assessment, Health Care, ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::bacteriemia, Intensive Care Units/statistics & numerical data, Female, Cross Infection / mortality, Europe / epidemiology, Drug Monitoring, Drug Monitoring/methods, Bacterièmia - Tractament, Critical Illness, ICU MORTALITY, Hospital-acquired bloodstream infections, Bacteremia / mortality, Outcome and Process Assessment, Intensive Care Units / organization & administration, HEALTH CARE::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care), Process indicator, Europe/epidemiology, Cross Infection / drug therapy, Humans, Bacteraemia, Drug Monitoring / statistics & numerical data, DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Bacteremia, Aged, Anti-Bacterial Agents / therapeutic use, ATENCIÓN DE SALUD::administración de los servicios de salud::calidad de la atención sanitaria::evaluación de resultados y procesos (atención a la salud), CARE, Bacteremia/mortality, Infeccions nosocomials, STATES CRITICAL ILLNESS, Health Care, Critical Illness/mortality, Anti-Bacterial Agents/therapeutic use, name=Critical Care and Intensive Care Medicine, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents, ENFERMEDADES::infecciones bacterianas y micosis::infección::infección hospitalaria, Drug Monitoring / methods, Avaluació de resultats (Assistència sanitària), Cross Infection/mortality, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos
Dateibeschreibung: application/pdf; application/zip; text/xml
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38498170
https://hdl.handle.net/11351/11576
https://archive-ouverte.unige.ch/unige:178039
https://doi.org/10.1007/s00134-024-07348-0
https://portal.findresearcher.sdu.dk/da/publications/ecc6921b-5278-4211-a83e-91f1ed36937e
https://doi.org/10.1007/s00134-024-07348-0
https://avesis.aybu.edu.tr/publication/details/2e1a33a0-d968-4636-b8cf-ad72d2062076/oai
https://avesis.erciyes.edu.tr/publication/details/2e1a33a0-d968-4636-b8cf-ad72d2062076/oai
https://www.repository.cam.ac.uk/handle/1810/369522
https://doi.org/10.1007/s00134-024-07348-0
https://www.repository.cam.ac.uk/handle/1810/364220
https://doi.org/10.17863/cam.105971
https://doi.org/10.1007/s00134-024-07348-0
https://biblio.ugent.be/publication/01JWZMYMYCQW30M89CY27YMFAF
http://doi.org/10.1007/s00134-024-07348-0
http://hdl.handle.net/1854/LU-01JWZMYMYCQW30M89CY27YMFAF
https://biblio.ugent.be/publication/01JWZMYMYCQW30M89CY27YMFAF/file/01JWZMZABR450E43DQZX0845N3
https://hdl.handle.net/2318/1969755
https://doi.org/10.1007/s00134-024-07348-0 -
7
Autoren: et al.
Quelle: Ther Drug Monit
Therapeutic drug monitoring, vol. 46, no. 6, pp. 828-836Schlagwörter: 03 medical and health sciences, 0302 clinical medicine, Humans, Olanzapine/blood, Male, Female, Drug Monitoring/methods, Middle Aged, Adult, Antipsychotic Agents/blood, Antipsychotic Agents/therapeutic use, Antipsychotic Agents/pharmacokinetics, Mental Disorders/drug therapy, Mental Disorders/blood, Benzodiazepines/blood, Benzodiazepines/therapeutic use, Benzodiazepines/pharmacokinetics, Cohort Studies, Aged, Smoking/blood, Sex Factors, Body Weight, Young Adult, Age Factors, clinical factors, olanzapine, plasma concentrations, therapeutic drug monitoring, Original Article, 3. Good health
Dateibeschreibung: application/pdf
-
8
Autoren: et al.
Quelle: Therapeutic Drug Monitoring. 46:281-284
Schlagwörter: Adult, Bipolar Disorder, Neuromyelitis Optica/therapy, Neuromyelitis Optica, Antimanic Agents/therapeutic use, Plasmapheresis, Middle Aged, Lithium, Plasmapheresis/methods, 3. Good health, Intensive Care Units, Lithium/blood, Antimanic Agents, Bipolar Disorder/therapy, Humans, Female, Drug Monitoring, Drug Monitoring/methods
-
9
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Thrombosis Research. 237:171-180
Schlagwörter: Oral, MESH: Recombinant Proteins, [SDV]Life Sciences [q-bio], Idarucizumab, Antidotes, MESH: Factor Xa Inhibitors / therapeutic use, Administration, Oral, Humanized, Antibodies, Monoclonal, Humanized, MESH: Antidotes* / therapeutic use, Monoclonal, Humans, Ciraparantag, MESH: Humans, MESH: Drug Monitoring / methods, MESH: Antibodies, Anticoagulants, Laboratory monitoring, Andexanet alfa, Recombinant Proteins, 3. Good health, MESH: Anticoagulants* / therapeutic use, MESH: Factor Xa, [SDV] Life Sciences [q-bio], Antidote, Factor Xa, MESH: Administration, Drug Monitoring, Direct oral anticoagulant, Factor Xa Inhibitors
Dateibeschreibung: application/pdf
-
10
Autoren: et al.
Quelle: Therapeutic Drug Monitoring. 46:291-308
Schlagwörter: 0301 basic medicine, Infliximab/therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Gastrointestinal Agents, Inflammatory Bowel Diseases/drug therapy, Gastrointestinal Agents/therapeutic use, Humans, Drug Monitoring, Inflammatory Bowel Diseases, Drug Monitoring/methods, Infliximab, 3. Good health
-
11
Autoren: et al.
Quelle: Int J Tuberc Lung Dis
Schlagwörter: Tuberculosis/drug therapy, Adult, Romania, Humans, Tuberculosis, Original Articles, Drug Monitoring, Ukraine, Drug Monitoring/methods, 3. Good health, Retrospective Studies
-
12
Autoren: et al.
Quelle: Wieringa, J W, Kruizinga, M D, Driessen, G J A, van der Woude, C J & Julsgaard, M 2024, 'Validation of the pharmacokinetic model for anti-TNFα clearance in infants exposed to anti-TNFα during pregnancy', Journal of Crohn's and Colitis, vol. 18, no. 4, jjad172, pp. 506-515. https://doi.org/10.1093/ecco-jcc/jjad172
Wieringa, J W, Kruizinga, M D, Driessen, G J A, van der Woude, C J & Julsgaard, M 2024, 'Validation of the pharmacokinetic model for anti-TNFα clearance in infants exposed to anti-TNFα during pregnancy', Journal of Crohn's and Colitis, vol. 18, no. 4, pp. 506-515. https://doi.org/10.1093/ecco-jcc/jjad172Schlagwörter: Adalimumab/pharmacokinetics, Fetal Blood/chemistry, clearance, Infliximab/pharmacokinetics, Anti-tumour necrosis factor alpha, SDG 3 - Good Health and Well-being, inflammatory bowel disease, Pregnancy, Anti-tumor necrosis factor alpha, Humans, Prospective Studies, pregnancy outcome, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha, Adalimumab, Infant, Newborn, Infant, Bayes Theorem, vaccination, Fetal Blood, Infliximab, 3. Good health, Female, pregnancy, Drug Monitoring, Drug Monitoring/methods, pharmacokinetics
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37823516
https://vbn.aau.dk/ws/files/556178820/Wieringa_et_al._2023_._Validation_of_the_pharmacokinetic_model_for_anti-_TNF_clearance_in_infants_exposed_to_anti-_TNF_during_pregnancy.pdf
https://vbn.aau.dk/da/publications/3de4d72b-073c-44a5-ab44-3e850ac8286a
https://doi.org/10.1093/ecco-jcc/jjad172
http://www.scopus.com/inward/record.url?scp=85191104459&partnerID=8YFLogxK
https://pure.eur.nl/en/publications/e33aa1f6-f0fc-4c0c-9243-8f0f53d3efab
https://doi.org/10.1093/ecco-jcc/jjad172
https://cris.maastrichtuniversity.nl/en/publications/b145a2b5-2a28-48ac-b8ec-9a94bd8589b1
https://doi.org/10.1093/ecco-jcc/jjad172
https://pure.au.dk/portal/en/publications/ffcc309e-bf74-4da5-9fc6-aba2fab32d36
https://doi.org/10.1093/ecco-jcc/jjad172 -
13
Autoren: et al.
Quelle: ISSN: 1432-6981 ; Clinical oral investigations, vol. 29, no. 9 (2025) 420.
Schlagwörter: info:eu-repo/classification/ddc/617.6, Adult, Amoxicillin / blood, Amoxicillin / pharmacokinetics, Anti-Bacterial Agents / blood, Anti-Bacterial Agents / pharmacokinetics, Azithromycin / blood, Azithromycin / pharmacokinetics, Blood Specimen Collection / methods, Capillaries, Chromatography, Liquid, Drug Monitoring / methods, Female, Humans, Male, Metronidazole / blood, Metronidazole / pharmacokinetics, Middle Aged, Periodontal Diseases / blood, Periodontal Diseases / drug therapy, Pilot Projects, Tandem Mass Spectrometry, Veins
Relation: info:eu-repo/semantics/altIdentifier/pmid/40848053; unige:189115
Verfügbarkeit: https://archive-ouverte.unige.ch/unige:189115
-
14
Autoren: et al.
Quelle: Molecules, vol. 30, no. 9, pp. 1866
Schlagwörter: Humans, Tandem Mass Spectrometry/methods, Cystic Fibrosis/drug therapy, Cystic Fibrosis/blood, Drug Monitoring/methods, Chromatography, Liquid/methods, Cystic Fibrosis Transmembrane Conductance Regulator/genetics, Quinolones/blood, Quinolones/pharmacokinetics, Aminophenols/blood, Aminophenols/pharmacokinetics, Aminopyridines/blood, Aminopyridines/pharmacokinetics, Benzodioxoles/blood, Benzodioxoles/pharmacokinetics, Reproducibility of Results, Indoles, CFTR modulators, LC-MS/MS, cystic fibrosis, method development, pharmacokinetics, precision medicine, quantification, therapeutic drug monitoring, validation
Dateibeschreibung: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/40363673; info:eu-repo/semantics/altIdentifier/eissn/1420-3049; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_6797F7B6EBCD1; https://serval.unil.ch/notice/serval:BIB_6797F7B6EBCD; https://serval.unil.ch/resource/serval:BIB_6797F7B6EBCD.P001/REF.pdf
-
15
Autoren: et al.
Quelle: International Clinical Psychopharmacology. 39:23-28
Schlagwörter: Patient Outcome Assessment, Blood Specimen Collection, Blood Specimen Collection/methods, Humans, Drug Monitoring, Drug Monitoring/methods, Clozapine, Clozapine/therapeutic use, 3. Good health, Capillaries
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37551596
-
16
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Therapeutic Drug Monitoring. 45:223-228
Schlagwörter: Chromatography, Blood Specimen Collection, Everolimus* / therapeutic use, Dried Blood Spot Testing / methods, 01 natural sciences, Liver Transplantation, 0104 chemical sciences, 3. Good health, Liquid / methods, Drug Monitoring / methods, Humans, Everolimus, Dried Blood Spot Testing, Blood Specimen Collection / methods, Drug Monitoring, Chromatography, Liquid
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36127775
-
17
Autoren: et al.
Quelle: BMC infectious diseases. 21(1)
Schlagwörter: Adult, Antitubercular Agents: analysis, therapeutic use, Chromatography, Liquid, Drug Monitoring: methods, Female, Hair: chemistry, Humans, Male, Middle Aged, Mycobacterium tuberculosis: drug effects, Rifampin: pharmacology, Sensitivity and Specificity, Tandem Mass Spectrometry, Tuberculosis: drug therapy, Tuberculosis, Multidrug-Resistant: drug therapy
Zugangs-URL: https://escholarship.org/uc/item/0tb5d2zx
-
18
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Trials
Trials, Vol 25, Iss 1, Pp 1-24 (2024)
Trials, Vol. 25, no. 1, p. 669 [1-24] (2024)Schlagwörter: Male, Medicine (General), Child, preschool, therapeutic drug monitoring, Critically ill children, Critical Illness, vancomycin, Area under the concentration–time curve dosing, 4202 Epidemiology, Model-informed precision dosing, Microbial Sensitivity Tests, Therapeutic drug monitoring, Study Protocol, R5-920, Vancomycin, Anti-Bacterial Agents/administration & dosage, General & Internal Medicine, critical illness, Humans, Multicenter Studies as Topic, Child, 1102 Cardiorespiratory Medicine and Haematology, Randomized Controlled Trials as Topic, Vancomycin/administration & dosage, 3202 Clinical sciences, Infant, Newborn, Infant, 1103 Clinical Sciences, 4203 Health services and systems, Anti-Bacterial Agents, Cardiovascular System & Hematology, Randomized controlled trial, Child, Preschool, Area Under Curve, Randomized Controlled Trial, Female, Beneficial Trial Consortium, Drug Monitoring, Drug Monitoring/methods
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39390583
https://doaj.org/article/863e04f58ffe40869fb6f84dbeb1bc12
https://lirias.kuleuven.be/handle/20.500.12942/760818
https://doi.org/10.1186/s13063-024-08512-z
https://hdl.handle.net/2078.1/294756
https://biblio.vub.ac.be/vubir/a-multicentric-randomized-controlled-clinical-trial-to-study-the-impact-of-bedside-modelinformed-precision-dosing-of-vancomycin-in-critically-ill-childrenbeneficial-trial(2432fc28-d25e-4c09-b914-70a7dced526c).html -
19
Autoren: et al.
Quelle: Molecules
Molecules, Vol 30, Iss 9, p 1866 (2025)
Molecules, vol. 30, no. 9, pp. 1866Schlagwörter: Indoles, Cystic Fibrosis, therapeutic drug monitoring, precision medicine, Organic chemistry, Cystic Fibrosis Transmembrane Conductance Regulator, Aminopyridines, Reproducibility of Results, Quinolones, CFTR modulators, Aminophenols, Article, cystic fibrosis, QD241-441, Tandem Mass Spectrometry, Humans, Benzodioxoles, LC-MS/MS, Drug Monitoring, pharmacokinetics, Tandem Mass Spectrometry/methods, Cystic Fibrosis/drug therapy, Cystic Fibrosis/blood, Drug Monitoring/methods, Chromatography, Liquid/methods, Cystic Fibrosis Transmembrane Conductance Regulator/genetics, Quinolones/blood, Quinolones/pharmacokinetics, Aminophenols/blood, Aminophenols/pharmacokinetics, Aminopyridines/blood, Aminopyridines/pharmacokinetics, Benzodioxoles/blood, Benzodioxoles/pharmacokinetics, method development, quantification, validation, Chromatography, Liquid
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40363673
https://doaj.org/article/45928534da5e41dfa358f10acef4a3c0
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_6797F7B6EBCD1
https://serval.unil.ch/resource/serval:BIB_6797F7B6EBCD.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_6797F7B6EBCD -
20
Autoren: et al.
Quelle: Kawano-Dourado, L, Kristianslund, E K, Zeraatkar, D, Jani, M, Makharia, G, Hazlewood, G, Smith, C, Jess, T, Stabell, C, Schatten, A, Owen, A, Gehin, J, Katsidzira, L, Weinberg, D, Bauer-Ventura, I, Tugwell, P, Moayyedi, P, Cecchi, A V W, Shimabuco, A, Seterelv, S, Gyuatt, G, Agoritsas, T & Vandvik, P O 2024, 'Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline', The BMJ, vol. 387, e079830. https://doi.org/10.1136/bmj-2024-079830
Kawano-Dourado, L, Klami Kristianslund, E, Zeraatkar, D, Jani, M, Makharia, G, Hazlewood, G, Smith, C, Jess, T, Stabell, C, Schatten, A, Owen, A, Gehin, J, Katsidzira, L, Weinberg, D, Bauer-Ventura, I, Tugwell, P, Moayyedi, P, Wolff Cecchi, A V, Shimabuco, A, Seterelv, S, Gyuatt, G, Agoritsas, T & Olav Vandvik, P 2024, 'Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis : A clinical practice guideline', BMJ., vol. 387, e079830. https://doi.org/10.1136/bmj-2024-079830Schlagwörter: Adult, Inflammatory Bowel Diseases / drug therapy, Psoriasis / blood, Meta-Analysis as Topic, Adalimumab/therapeutic use, Inflammatory Bowel Diseases/drug therapy, Adalimumab / blood, Psoriasis/drug therapy, Humans, Psoriasis, Adalimumab / therapeutic use, Psoriasis / drug therapy, Biological Products, Biological Products / administration & dosage, Adalimumab, Drug Monitoring / standards, Inflammatory Bowel Diseases, Adalimumab / administration & dosage, Practice Guidelines as Topic, Drug Monitoring / methods, Inflammatory Bowel Diseases / blood, Biological Products / therapeutic use, Drug Monitoring, Biological Products/therapeutic use, Drug Monitoring/methods, Systematic Reviews as Topic
Dateibeschreibung: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39467592
http://www.scopus.com/inward/record.url?scp=85208082256&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/751264098/Kawano-Dourado_et_al._2024_._Proactive_therapeutic_drug_monitoring_of_biologic_drugs_in_adult_patients_with_inflammatory_bowel_disease_inflammatory_arthritis_or_psoriasis_-_a_clinical_practice_guideline.pdf
https://doi.org/10.1136/bmj-2024-079830
https://vbn.aau.dk/da/publications/28ba50bf-0b41-47fa-b778-be664008b009
https://archive-ouverte.unige.ch/unige:185740
https://doi.org/10.1136/bmj-2024-079830
Nájsť tento článok vo Web of Science 
Full Text Finder 
Full Text